carteolol and betaxolol

carteolol has been researched along with betaxolol in 34 studies

Research

Studies (34)

Timeframe	Studies, this research(%)	All Research%
pre-1990	5 (14.71)	18.7374
1990's	9 (26.47)	18.2507
2000's	15 (44.12)	29.6817
2010's	2 (5.88)	24.3611
2020's	3 (8.82)	2.80

Authors

Authors	Studies
Carrupt, PA; el Tayar, N; Testa, B; Van de Waterbeemd, H	1
Topliss, JG; Yoshida, F	1
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL	1
González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M	1
Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ	1
Hugues, FC; Le Jeunne, C; Munera, Y	1
Collignon-Brach, J	1
James, IM	1
Pillunat, LE; Stodtmeister, R	1
Zimmerman, TJ	1
Becker, EJ; Chen, Z; DeSantis, L; Hester, RK; McLaughlin, M	1
Frishman, WH; Fuksbrumer, MS; Tannenbaum, M	1
Cassels-Brown, A; Diggory, P; Fernandez, C	1
Hong, SJ; Wang, HZ; Wu, KY	2
Araie, M; Nagahara, M; Tamaki, Y; Tomidokoro, A; Tomita, K	1
Hayashi, E; Hayashi-Morimoto, R; Ishikawa, H; Sato, Y; Yoshitomi, T	1
Melena, J; Osborne, NN; Wood, JP	1
Chidlow, G; Melena, J; Osborne, NN	1
Kijlstra, A; Mulder, M; van Beek, LM; van Haeringen, NJ	1
Iga, T; Ito, K; Ohtani, H; Sawada, Y; Takayanagi, R; Tsuchiya, K; Yamada, Y	1
Barnett, MF; Haybittle, J; Parker, V; Watson, PG	1
Belcaro, GV; Cesarone, MR; De Sanctis, MT; Incandela, L; Laurora, G; Minicucci, R; Steigerwalt, RD	1
Ishibashi, Y; Muto, T; Roy, S; Sato, T	1
Clark, JI; Martin, RW; Vaezy, S; Zderic, V	1
Fong, JC; Hong, SJ; Wang, HZ; Wu, KY	1
Baudouin, C; Blondin, C; Cholley, B; Haeffner-Cavaillon, N; Hamard, P	1
Ignat, F	1
Ikeda, Y; Ishibashi, T; Kinoshita, S; Mori, K; Nakajima, N; Naruse, S	1
Jia, L; Li, Z; Wu, J; Xiao, X	1
Fůs, M; Lešták, J; Marešová, K; Weissová, I	1
Barbeau, M; Beauchemin, C; Cui, AX; Harasymowycz, P; Jobin-Gervais, K; Lachaine, J; Mathurin, K; Royer, C	1
Jedlowski, MF; Jedlowski, PM	1

Reviews

5 review(s) available for carteolol and betaxolol

Article	Year
Modeling of beta-adrenoceptors based on molecular electrostatic potential studies of agonists and antagonists. Journal of medicinal chemistry, 1988, Volume: 31, Issue:11 Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Models, Molecular; Receptors, Adrenergic, beta; Structure-Activity Relationship	1988
Pharmacologic effects of beta-blocking agents used in the management of glaucoma. Survey of ophthalmology, 1989, Volume: 33 Suppl Topics: Adrenergic beta-Antagonists; Betaxolol; Carteolol; Glaucoma; Heart Rate; Humans; Intraocular Pressure; Levobunolol; Metipranolol; Propanolamines; Solubility; Timolol	1989
Topical ophthalmic beta blockers: a comparative review. Journal of ocular pharmacology, 1993,Winter, Volume: 9, Issue:4 Topics: Administration, Topical; Adrenergic beta-Antagonists; Animals; Betaxolol; Carteolol; Drug Tolerance; Glaucoma; Humans; Intraocular Pressure; Levobunolol; Metipranolol; Ophthalmic Solutions; Timolol	1993
Topical ophthalmic beta-adrenergic blockade for the treatment of glaucoma and ocular hypertension. Journal of clinical pharmacology, 1994, Volume: 34, Issue:8 Topics: Administration, Topical; Adrenergic beta-Antagonists; Betaxolol; Carteolol; Glaucoma; Humans; Levobunolol; Metipranolol; Ocular Hypertension; Timolol	1994
Short-term efficacy of latanoprostene bunod for the treatment of open-angle glaucoma and ocular hypertension: a systematic literature review and a network meta-analysis. The British journal of ophthalmology, 2022, Volume: 106, Issue:5 Topics: Amides; Antihypertensive Agents; Bayes Theorem; Betaxolol; Bimatoprost; Brimonidine Tartrate; Carteolol; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Latanoprost; Network Meta-Analysis; Ocular Hypertension; Prostaglandins A; Prostaglandins F, Synthetic; Timolol; Travoprost	2022

Trials

6 trial(s) available for carteolol and betaxolol

Article	Year
Systemic effects of three beta-blocker eyedrops: comparison in healthy volunteers of beta 1- and beta 2-adrenoreceptor inhibition. Clinical pharmacology and therapeutics, 1990, Volume: 47, Issue:5 Topics: Adrenergic beta-Antagonists; Adult; Betaxolol; Carteolol; Female; Heart Rate; Humans; Isoproterenol; Male; Muscle, Smooth, Vascular; Myocardium; Ophthalmic Solutions; Randomized Controlled Trials as Topic; Timolol	1990
Early visual field changes with beta-blocking agents. Survey of ophthalmology, 1989, Volume: 33 Suppl Topics: Adrenergic beta-Antagonists; Betaxolol; Carteolol; Drug Evaluation, Preclinical; Follow-Up Studies; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Propanolamines; Timolol; Visual Fields	1989
Topical beta-blockade with intrinsic sympathomimetic activity offers no advantage for the respiratory and cardiovascular function of elderly people. Age and ageing, 1996, Volume: 25, Issue:6 Topics: Adrenergic beta-Antagonists; Aged; Aged, 80 and over; Airway Resistance; Betaxolol; Blood Pressure; Carteolol; Double-Blind Method; Female; Glaucoma, Open-Angle; Humans; Male; Middle Aged; Pulse; Spirometry; Sympathomimetics; Timolol	1996
Effects of topical adrenergic agents on tissue circulation in rabbit and human optic nerve head evaluated with laser speckle tissue circulation analyzer. Survey of ophthalmology, 1997, Volume: 42 Suppl 1 Topics: Administration, Topical; Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Adult; Animals; Betaxolol; Blood Circulation; Blood Flow Velocity; Blood Pressure; Carteolol; Double-Blind Method; Hemorheology; Humans; Intraocular Pressure; Ophthalmic Solutions; Optic Disk; Propanolamines; Quinazolines; Rabbits	1997
A 7 year prospective comparative study of three topical beta blockers in the management of primary open angle glaucoma. The British journal of ophthalmology, 2001, Volume: 85, Issue:8 Topics: Adrenergic beta-Antagonists; Aged; Betaxolol; Carteolol; Drug Therapy, Combination; Female; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Linear Models; Male; Prospective Studies; Survival Analysis; Timolol; Trabeculectomy; Treatment Outcome; Visual Fields	2001
Effects of switching from topical beta-blockers to latanoprost on intraocular pressure in patients with normal-tension glaucoma. Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics, 2008, Volume: 24, Issue:2 Topics: Adrenergic beta-Antagonists; Antihypertensive Agents; Betaxolol; Carteolol; Female; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Latanoprost; Male; Middle Aged; Ophthalmic Solutions; Propanolamines; Prospective Studies; Prostaglandins F, Synthetic; Time Factors	2008

Other Studies

23 other study(ies) available for carteolol and betaxolol

Article	Year
QSAR model for drug human oral bioavailability. Journal of medicinal chemistry, 2000, Jun-29, Volume: 43, Issue:13 Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship	2000
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling. Current drug discovery technologies, 2004, Volume: 1, Issue:4 Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration	2004
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors. Journal of medicinal chemistry, 2008, Nov-13, Volume: 51, Issue:21 Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship	2008
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification. Drug metabolism and disposition: the biological fate of chemicals, 2012, Volume: 40, Issue:12 Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship	2012
Pressure compliance test of the optic nerve head: influence of different antiglaucoma drugs. Survey of ophthalmology, 1989, Volume: 33 Suppl Topics: Acetazolamide; Adrenergic beta-Antagonists; Betaxolol; Carteolol; Glaucoma; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Optic Disk; Pilocarpine; Propanolamines; Timolol	1989
New topical beta-blockers for glaucoma. Drug and therapeutics bulletin, 1987, Aug-10, Volume: 25, Issue:16 Topics: Administration, Topical; Adrenergic beta-Antagonists; Betaxolol; Carteolol; Glaucoma; Humans; Metipranolol; Propanolamines	1987
The direct vascular relaxing action of betaxolol, carteolol and timolol in porcine long posterior ciliary artery. Survey of ophthalmology, 1994, Volume: 38 Suppl Topics: Animals; Arteries; Betaxolol; Calcium; Carteolol; Ciliary Body; Iliac Artery; Muscle, Smooth, Vascular; Nitroprusside; Rabbits; Swine; Timolol; Vasoconstriction	1994
Effects of pilocarpine and other antiglaucoma drugs on cultured human Tenon's fibroblast cells. Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics, 1997, Volume: 13, Issue:1 Topics: Adrenergic beta-Antagonists; Betaxolol; Carteolol; Cell Division; Cells, Cultured; Eye; Fibroblasts; Glaucoma; Humans; Levobunolol; Muscarinic Agonists; Pilocarpine; Thymidine; Timolol	1997
Effects of beta antagonists on mechanical properties in rabbit ciliary artery. Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie, 1999, Volume: 237, Issue:8 Topics: Adrenergic alpha-Agonists; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Betaxolol; Carteolol; Cholinergic Agonists; Ciliary Arteries; Dose-Response Relationship, Drug; Enzyme Inhibitors; Isoproterenol; Male; Muscle, Smooth, Vascular; Phenylephrine; Rabbits; Receptors, Adrenergic, alpha-1; Timolol; Vasoconstriction	1999
Betaxolol, a beta1-adrenoceptor antagonist, has an affinity for L-type Ca2+ channels. European journal of pharmacology, 1999, Aug-13, Volume: 378, Issue:3 Topics: Adrenergic beta-Antagonists; Animals; Betaxolol; Binding, Competitive; Calcium Channels; Carteolol; Cerebral Cortex; Diltiazem; Dose-Response Relationship, Drug; Female; Male; Membranes; Nitrendipine; Propranolol; Radioligand Assay; Rats; Rats, Wistar; Stereoisomerism; Timolol; Tritium	1999
Betaxolol, a beta(1)-adrenoceptor antagonist, reduces Na(+) influx into cortical synaptosomes by direct interaction with Na(+) channels: comparison with other beta-adrenoceptor antagonists. British journal of pharmacology, 2000, Volume: 130, Issue:4 Topics: Adrenergic beta-1 Receptor Antagonists; Adrenergic beta-Antagonists; Animals; Atenolol; Batrachotoxins; Betaxolol; Binding, Competitive; Carteolol; Cerebral Cortex; Dose-Response Relationship, Drug; Kinetics; Levobunolol; Membranes; Propranolol; Rats; Rats, Wistar; Saxitoxin; Sodium; Sodium Channels; Sodium Radioisotopes; Synaptosomes; Timolol; Tritium	2000
Topical ophthalmic beta blockers may cause release of histamine through cytotoxic effects on inflammatory cells. The British journal of ophthalmology, 2000, Volume: 84, Issue:9 Topics: Administration, Topical; Adrenergic beta-Antagonists; Basophils; Betaxolol; Carteolol; Cells, Cultured; Dose-Response Relationship, Drug; Histamine Release; Humans; L-Lactate Dehydrogenase; Leukocytes; Metipranolol; Timolol	2000
Assessment of systemic adverse reactions induced by ophthalmic beta-adrenergic receptor antagonists. Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics, 2001, Volume: 17, Issue:3 Topics: Administration, Oral; Administration, Topical; Adrenergic beta-Antagonists; Betaxolol; Cardiovascular Diseases; Carteolol; Exercise; Forced Expiratory Volume; Heart; Heart Rate; Humans; Lung; Ophthalmic Solutions; Propanolamines; Receptors, Adrenergic, beta-1; Receptors, Adrenergic, beta-2; Respiration Disorders; Retrospective Studies; Timolol	2001
Ocular and retrobulbar blood flow in ocular hypertensives treated with topical timolol, betaxolol and carteolol. Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics, 2001, Volume: 17, Issue:6 Topics: Administration, Topical; Adult; Aged; Antihypertensive Agents; Betaxolol; Blood Flow Velocity; Carteolol; Ciliary Arteries; Humans; Middle Aged; Ocular Hypertension; Ophthalmic Artery; Retinal Artery; Timolol	2001
Short-term effect of beta-adrenoreceptor blocking agents on ocular blood flow. Current eye research, 2001, Volume: 23, Issue:4 Topics: Administration, Topical; Adrenergic beta-Antagonists; Animals; Betaxolol; Blood Flow Velocity; Blood Pressure; Carteolol; Choroid; Ciliary Body; Eye; Heart Rate; Intraocular Pressure; Rabbits; Random Allocation; Regional Blood Flow; Retinal Vessels; Timolol; Vascular Resistance	2001
Ocular drug delivery using 20-kHz ultrasound. Ultrasound in medicine & biology, 2002, Volume: 28, Issue:6 Topics: Adrenergic beta-Antagonists; Animals; Atenolol; Betaxolol; Carteolol; Cornea; Drug Delivery Systems; Epithelium; Models, Animal; Permeability; Rabbits; Timolol; Ultrasonics	2002
Effects of commercial antiglaucoma drugs to glutamate-induced [Ca2+)]i increase in cultured neuroblastoma cells. Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics, 2003, Volume: 19, Issue:3 Topics: Animals; Antihypertensive Agents; Betaxolol; Brimonidine Tartrate; Calcium; Carteolol; Cell Death; Dose-Response Relationship, Drug; Epinephrine; Glaucoma; Glutamic Acid; Latanoprost; Mice; Neuroblastoma; Neurons; Neuroprotective Agents; Pilocarpine; Prostaglandins F, Synthetic; Quinoxalines; Sulfonamides; Thiazines; Thiophenes; Timolol; Tumor Cells, Cultured	2003
In vitro effects of preserved or preservative-free antiglaucoma medications on human complement system. Current eye research, 2003, Volume: 27, Issue:4 Topics: Adrenergic beta-Antagonists; Benzalkonium Compounds; Betaxolol; Carteolol; Complement System Proteins; Glaucoma; Humans; Intraocular Pressure; Latanoprost; Preservatives, Pharmaceutical; Prostaglandins F, Synthetic; Timolol	2003
[Neuroprotection and vasoprotection in glaucoma]. Oftalmologia (Bucharest, Romania : 1990), 2004, Volume: 48, Issue:2 Topics: Antihypertensive Agents; Betaxolol; Brimonidine Tartrate; Carteolol; Drug Therapy, Combination; Glaucoma; Humans; Intraocular Pressure; Latanoprost; Neuroprotective Agents; Ophthalmic Solutions; Prostaglandins F, Synthetic; Quinoxalines; Sulfonamides; Thiophenes; Treatment Outcome	2004
Cellular cytotoxicity of antiglaucoma drugs in cultured corneal endothelial cells. The Kaohsiung journal of medical sciences, 2007, Volume: 23, Issue:3 Topics: Animals; Betaxolol; Carteolol; Cattle; Cells, Cultured; Dose-Response Relationship, Drug; Endothelial Cells; Endothelium, Corneal; Glaucoma; L-Lactate Dehydrogenase; Levobunolol; Pilocarpine; Timolol	2007
Enantioseparation of chiral β-blockers using polynorepinephrine-coated nanoparticles and chiral capillary electrophoresis. Analytical and bioanalytical chemistry, 2019, Volume: 411, Issue:10 Topics: Adrenergic beta-Antagonists; Betaxolol; Carteolol; Electrophoresis, Capillary; Equipment Design; Humans; Limit of Detection; Magnetics; Magnetite Nanoparticles; Metoprolol; Norepinephrine; Solid Phase Microextraction; Stereoisomerism	2019
Betaxolol, Brimonidin and Carteolol in the Therapy of Normal-Tension Glaucoma. Ceska a slovenska oftalmologie : casopis Ceske oftalmologicke spolecnosti a Slovenske oftalmologicke spolecnosti, 2020,Spring, Volume: 76, Issue:2 Topics: Betaxolol; Carteolol; Evoked Potentials, Visual; Glaucoma; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Middle Aged	2020
Topical ophthalmic beta-blockers are associated with ocular pseudopemphigoid: A pharmacovigilance study of antiglaucoma medications utilising the FDA adverse event reporting system. The Australasian journal of dermatology, 2022, Volume: 63, Issue:2 Topics: Adrenergic beta-Antagonists; Antiglaucoma Agents; Betaxolol; Carteolol; Humans; Irritants; Ophthalmic Solutions; Pharmacovigilance; Preservatives, Pharmaceutical	2022